You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Minister promises ‘major savings’ in new drugs price deal

By Dermot - 20th Jul 2016 | 2 views

Minister Simon Harris said the deal will save an estimated €600 million, plus additional savings from non-IPHA companies

“The pricing provisions in this agreement represent a significant improvement on those contained in the previous agreement,” said Minister Harris.

“They will see an expansion of the reference basket used to set prices in Ireland from the present nine to 14 countries, including for the first time Greece, Italy and Portugal.

“The agreement also includes, for the first time, an annual price realignment to ensure that the prices of medicines in Ireland reduce in line with price changes across the reference countries.

“A rebate of 5.25 per cent rising to 5.5 per cent will further reduce the overall cost of medicines in the years ahead.”

However, aspects of the deal have been criticised by the Healthcare Enterprise Alliance (HEA).

“The inclusion of an artificial pricing clause that blocks better value biosimilar medicines entering the market is profoundly disappointing,” said Ms Sandra Gannon, HEA President.

“It leaves Ireland alone in Europe and indeed one of the only countries in the world preventing competition in this part of the medicines market.”

However at a press conference at government buildings earlier today, Minister Harris insisted Ireland is open for business for biosimilar companies.

“I want to send a very clear message to biosimilar companies that this country is very much open for business to biosimilars,” the Minister said in reply to a question from the <em><strong>Medical Independent </strong></em>at the conference.

“In fact we are actively developing in the Department of Health a policy in relation to how we can see greater use of biosimilars. I am considering legislation in this regard as well. So Ireland is absolutely open for business for biosimilars.”

Dr Leisha Daly, President of IPHA, who led its delegation during negotiations, said: “It is essential that patients have early access to life- saving and life-enhancing new medicines. This Agreement is the best way to make that happen. It offers a clear process and sustainable pricing so that new medicines can be made available quickly to patients in Ireland. With this Agreement in place, patients and their doctors can rightly expect that priority will be given to funding innovative, new medicines in the health services.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]